Literature DB >> 25201194

The p53-Mdm2 loop: a critical juncture of stress response.

Yaara Levav-Cohen1, Zehavit Goldberg, Kah Hin Tan, Osnat Alsheich-Bartok, Valentina Zuckerman, Sue Haupt, Ygal Haupt.   

Abstract

The presence of a functional p53 protein is a key factor for the proper suppression of cancer development. A loss of p53 activity, by mutations or inhibition, is often associated with human malignancies. The p53 protein integrates various stress signals into a growth restrictive cellular response. In this way, p53 eliminates cells with a potential to become cancerous. Being a powerful decision maker, it is imperative that p53 will be activated properly, efficiently and temporarily in response to stress. Equally important is that p53 activation will be extinguished upon recovery from stress, and that improper activation of p53 will be avoided. Failure to achieve these aims is likely to have catastrophic consequences for the organism. The machinery that governs this tight regulation is largely based on the major inhibitor of p53, Mdm2, which both blocks p53 activities and promotes its destabilization. The interplay between p53 and Mdm2 involves a complex network of positive and negative feedback loops. Relief from Mdm2 suppression is required for p53 to be stabilized and activated in response to stress. Protection from Mdm2 entails a concerted action of modifying enzymes and partner proteins. The association of p53 with the PML-nuclear bodies may provide an infrastructure in which this complex regulatory network can be orchestrated. In this chapter we use examples to illustrate the regulatory machinery that drives this network.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25201194     DOI: 10.1007/978-94-017-9211-0_9

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  20 in total

1.  A study of bias and increasing organismal complexity from their post-translational modifications and reaction site interplays.

Authors:  Oliver Bonham-Carter; Ishwor Thapa; Steven From; Dhundy Bastola
Journal:  Brief Bioinform       Date:  2016-01-13       Impact factor: 11.622

2.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

3.  Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.

Authors:  Chuandong Fan; Xinjiang Wang
Journal:  Cell Cycle       Date:  2017-02-06       Impact factor: 4.534

4.  DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.

Authors:  Alejandro Parrales; Atul Ranjan; Swathi V Iyer; Subhash Padhye; Scott J Weir; Anuradha Roy; Tomoo Iwakuma
Journal:  Nat Cell Biol       Date:  2016-10-24       Impact factor: 28.824

5.  FGFR and PTEN signaling interact during lens development to regulate cell survival.

Authors:  Blake R Chaffee; Thanh V Hoang; Melissa R Leonard; Devin G Bruney; Brad D Wagner; Joseph Richard Dowd; Gustavo Leone; Michael C Ostrowski; Michael L Robinson
Journal:  Dev Biol       Date:  2016-01-05       Impact factor: 3.582

Review 6.  Exploiting the yeast stress-activated signaling network to inform on stress biology and disease signaling.

Authors:  Yi-Hsuan Ho; Audrey P Gasch
Journal:  Curr Genet       Date:  2015-05-10       Impact factor: 3.886

7.  Fabrication Of Gold Nanoparticles In Absence Of Surfactant As In Vitro Carrier Of Plasmid DNA.

Authors:  Rania S Abdel-Rashid; Samia M Omar; Mohammed S Teiama; Ahmed Khairy; Mohamed Magdy; Badawi Anis
Journal:  Int J Nanomedicine       Date:  2019-10-22

Review 8.  The interplay between mutant p53 and the mevalonate pathway.

Authors:  Alejandro Parrales; Elizabeth Thoenen; Tomoo Iwakuma
Journal:  Cell Death Differ       Date:  2017-12-13       Impact factor: 15.828

9.  Evolving sensitivity balances Boolean Networks.

Authors:  Jamie X Luo; Matthew S Turner
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

10.  NORE1A Regulates MDM2 Via β-TrCP.

Authors:  M Lee Schmidt; Diego F Calvisi; Geoffrey J Clark
Journal:  Cancers (Basel)       Date:  2016-03-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.